Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:28:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and older Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:59:29.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Minor revision: updated from v3.2.0 to v3.3.2 and no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:56.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the notice about government funding and potential delays. The page no longer displays operating status information.
    Difference
    0.4%
    Check dated 2025-11-17T19:19:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Between the old and new screenshots, core trial information (title, conditions, eligibility criteria, endpoints, enrollment location, and contact) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:42:19.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T04:25:00.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.